{"entity":{"type":"insider","cik":"0002006772","url":"/insider/0002006772","json_url":"/insider/0002006772.json","name":"ARCH Venture Fund XIII, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2025-02-03","last":"2026-06-24","span_basis":"filed_date"},"name_variants":[{"name":"ARCH Venture Fund XIII, L.P.","source":"filing","n_filings":3,"first_seen":"2025-02-03","last_seen":"2026-06-24"}],"transactions":[{"id":5761337,"accession":"0001012975-26-000564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-26-000564","line_url":"/filing/0001012975-26-000564#line-1","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"Kardigan, Inc.","issuer_ticker":"KARD","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"GILLIS STEVEN; CRANDELL KEITH; ARCH Venture Partners XIII, L.P.; ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XIII, LLC; Burow Kristina; NELSEN ROBERT","owner_display_name":"GILLIS STEVEN","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":20000000.0,"total_display":"20,000,000.00","total_whole":"20,000,000","shares_owned_after":15042035.0,"shares_owned_after_display":"15,042,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5832821,"accession":"0001012975-26-000234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-26-000234","line_url":"/filing/0001012975-26-000234#line-1","is_derivative":false,"issuer_cik":"0001202769","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001202769","owner_cik":null,"owner_name":"GILLIS STEVEN; CRANDELL KEITH; Burow Kristina; BYBEE CLINTON; NELSEN ROBERT; ARCH Venture Partners XIII, L.P.; BERNS PAUL L; ARCH Venture Partners XIII, LLC; ARCH Venture Fund XIII, L.P.","owner_display_name":"GILLIS STEVEN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":488090.0,"shares_display":"488,090","price_per_share":25.61,"price_display":"25.61","price_state":"stated","total_value":12499984.9,"total_display":"12,499,984.90","total_whole":"12,499,985","shares_owned_after":1426528.0,"shares_owned_after_display":"1,426,528","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-09","scope":"insider"},{"id":4027194,"accession":"0000950170-25-012579","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-012579","line_url":"/filing/0000950170-25-012579","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"Metsera, Inc.","issuer_ticker":"MTSR","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"ARCH Venture Fund XII, L.P.; ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XII, L.P.; ARCH Venture Partners XII, LLC; ARCH Venture Partners XIII, L.P.; ARCH Venture Partners XIII, LLC; CRANDELL KEITH; GILLIS STEVEN; NELSEN ROBERT","owner_display_name":"ARCH Venture Fund XII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2222222.0,"shares_display":"2,222,222","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":39999996.0,"total_display":"39,999,996.00","total_whole":"39,999,996","shares_owned_after":18503128.0,"shares_owned_after_display":"18,503,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002123613","name":"Kardigan, Inc.","url":"/issuer/0002123613","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-06-24","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001806952","name":"Lyell Immunopharma, Inc.","url":"/issuer/0001806952","role":"Ten percent owner","n_filings":1,"first_seen":"2026-03-09","last_seen":"2026-03-09"},{"type":"issuer","type_label":"ISSUER","cik":"0002040807","name":"Metsera, Inc.","url":"/issuer/0002040807","role":"Ten percent owner","n_filings":1,"first_seen":"2025-02-03","last_seen":"2025-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002006772","retrieved_at":"2026-08-23T21:37:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}